Late course three-dimensional conformal radiotherapy for esophageal carcinoma

Jin Hu(Wuhan University of Technology), Xianfu Li(North Sichuan Medical University), Bangxian Tan(Affiliated Hospital of North Sichuan Medical College), Tao Ren(Affiliated Hospital of North Sichuan Medical College), Daiyuan Ma(North Sichuan Medical University), Mi Liu(Chinese Center For Disease Control and Prevention), Yeqing Zhou(Affiliated Hospital of North Sichuan Medical College)
The Chinese-German Journal of Clinical Oncology
March 1, 2011
10.1007/s10330-011-0750-6
Cited by 1

Related Papers

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|2022|267
Leukemogenic Chromatin Alterations Promote AML Leukemia Stem Cells via a KDM4C-ALKBH5-AXL Signaling Axis
|Cell stem cell|2020|251
YBX1 is required for maintaining myeloid leukemia cell survival by regulating <i>BCL2</i> stability in an m6A-dependent manner
|Blood|2021|214
Differential m6A RNA landscapes across hematopoiesis reveal a role for IGF2BP2 in preserving hematopoietic stem cell function
|Cell stem cell|2021|122
Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial
|Radiotherapy and Oncology|2017|104